Back to Search Start Over

<scp>Pan‐HER</scp> inhibitors overcome lorlatinib resistance caused by <scp>NRG1</scp> / <scp>HER3</scp> activation in <scp> ALK </scp> ‐rearranged lung cancer

Authors :
Hirokazu Taniguchi
Kazumasa Akagi
Yosuke Dotsu
Tadaaki Yamada
Sawana Ono
Erika Imamura
Hiroshi Gyotoku
Shinnosuke Takemoto
Hiroyuki Yamaguchi
Triparna Sen
Seiji Yano
Hiroshi Mukae
Source :
Cancer Science. 114:164-173
Publication Year :
2022
Publisher :
Wiley, 2022.

Subjects

Subjects :
Cancer Research
Oncology
General Medicine

Details

ISSN :
13497006 and 13479032
Volume :
114
Database :
OpenAIRE
Journal :
Cancer Science
Accession number :
edsair.doi...........f7db87ab1a81642b66e5a26e80fcc0ae
Full Text :
https://doi.org/10.1111/cas.15579
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details